Rani Therapeutics (RANI) analyst forecast and price target
Analyst forecast
Consensus of 4 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Aug 21, 2026 |
| Chardan Capital | Initiated Coverage | Buy | $6.00 | Aug 18, 2026 |
| Canaccord Genuity | Maintained | Buy | $5.00 | May 20, 2026 |
| Canaccord Genuity | Maintained | Buy | $5.00 from $9.00 | Apr 1, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Mar 27, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $11.00 | Jan 9, 2026 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $11.00 | Oct 21, 2025 |
| Maxim Group | Maintained | Buy | $10.00 from $5.00 | Oct 20, 2025 |
| Oppenheimer | Maintained | Outperform | $4.00 from $14.00 | May 16, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Apr 3, 2025 |
| Canaccord Genuity | Maintained | Buy | $9.00 | Feb 26, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Feb 7, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Nov 19, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 | Oct 18, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $9.00 from $13.00 | Aug 16, 2024 |
| Oppenheimer | Initiated Coverage | Outperform | $17.00 | Aug 2, 2024 |
| HC Wainwright & Co. | Maintained | Buy | $13.00 | Jun 25, 2024 |
| Maxim Group | Initiated Coverage | Buy | $15.00 | Jun 14, 2024 |
| Rodman & Renshaw | Initiated Coverage | Buy | $10.00 | Jun 13, 2024 |
| BTIG | Maintained | Buy | $14.00 from $7.00 | May 9, 2024 |
Frequently asked questions
Is RANI a buy, sell, or hold?
Analysts covering Rani Therapeutics currently average a Buy rating: 4 buy, 0 hold and 0 sell, from 4 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on RANI?
On Aug 21, 2026, HC Wainwright & Co. maintained Rani Therapeutics at Buy with a price target of $11.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.